Paediatrics: from development to commercialisation
With a wealth of experience in paediatric medication, we understand the unique challenges faced in developing, manufacturing and packaging treatment specifically tailored for young patients. Offering comprehensive solutions which ensure the safety, efficacy, and appropriate dosing of medications for children. We recognise that paediatric patients span a wide age range, from newborn to adolescents and all have unique needs and requirements.
Development
Almac’s formulation development scientists specialise in creating age appropriate and palatable drug formulations. Considering factors such as taste, texture, dosage forms and, ease of administration, we develop formulations that are both effective and well-tolerated by paediatric patients. We understand and adhere to all regulatory guidelines to ensure that our product meets the highest standard of quality and safety standard.
Manufacturing
Our manufacturing facilities are equipped with cutting-edge technology to produce the highest quality medications for paediatric patients. Our manufacturing capabilities include:
| Bulk manufacture | Bulk unit forms | Dosing |
|
• Dispensing • Blending • Dry granulation • Wet granulation/fluid bed processing • Automated (mini) tablet compression • Mini tablet coating • Mini tablet encapsulation |
• Mini tablets • Powders/granules • Liquids • Orodispersible |
• Stick-packing • Sachet filling • Powder in bottle filling • Liquid in bottle • Liquid in capsules |
Packaging
Almac’s comprehensive range of paediatric packaging options ensures safety, convenience, and adherence to regulatory standards for children’s medications. Our packaging facilities are equipped with high-level technology to provide the highest quality packaging. Our capabilities include:
| Primary packaging | Secondary labelling and packaging |
|
• Stick packs • Sachets • Bottling and vials • Blister packs |
• Vials • Ampoules • Syringes • Wallets / blister packs • Cartons • Complex kit Assembly |
A member of the European Paediatric Formulation Initiative (EUPFI)
As a member of the EUPFI, Almac Pharma Services’ can contribute to improving access to paediatric medicines by sharing their expertise in this field and collaborating with other industry, academic and regulatory expert partners to identify innovative solutions to the challenges associated with developing medicines for children. By aligning with EuPFI’s mission, Almac continues its contribution to improving paediatric healthcare worldwide.
Single provider advantage
Providing development, manufacture and commercial services from a single source ensures that the formulation and processing knowledge gained throughout the development phase is effectively transferred to ongoing commercial supply for a seamless experience.
Our experienced teams have successfully delivered multiple Paediatric formulations to development and commercialisation from our custom-built facilities.
- A trusted commercial partner for some of the world’s leading orphan drugs.
- We offer full flexibility of scale for our commercial clients.
- Strong track record in continued successful delivery of low volume/high value products through flexible, innovative packaging tailored to suit to paediatric and niche medicines.
